Track topics on Twitter Track topics that are important to you
NeoGenomics Inc. netted $117.5mm through a public offering of 9.8mm common shares at $12.75. The company offers genetic testi...
Original Article: Public offering nets $117.5mm for NeoGenomicsNEXT ARTICLE
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...